SCHEMBL23329677

SCHEMBL23329677

Cc1ccc(-c2ccc(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccc(-c7ccccc7)cc5n6-c5ccccc5)ccc43)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ATM Q13315 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
AKR1C4 P17516 1/20 0.42
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
TSPO P30536 1/20 0.41
ALDH1A1 P00352 8/20 0.41
RXFP1 Q9HBX9 1/20 0.41
AVPR1A P37288 1/20 0.41
HPGD P15428 2/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PTGER4 P35408 1/20 0.39
HDAC4 P56524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15248190 1.00 KDM4E (0.50) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL20408490 0.97 KDM4E (0.53) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL15747036 0.97 KDM4E (0.53) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL24099809 0.97 KDM4E (0.53) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL17032737 0.96 KDM4E (0.49) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL17032735 0.96 KDM4E (0.49) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL21037660 0.96 ALDH1A1 (0.42) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL19762209 0.96 KDM4E (0.55) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL19001868 0.96 KDM4E (0.46) KDM4EATML3MBTL1AKR1C4AKR1C3
SCHEMBL15446092 0.94 KDM4E (0.50) KDM4EATML3MBTL1AKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130304-A1 COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130304-A1 COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OR10J3, OCIAD1 KDM4E 3989/4885ATM 3687/4885L3MBTL1 3791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.